Amyloid precursor-like proteins (APLPs), APLP1 and APLP2, are members
of a gene family which include the Alzheimer beta-amyloid precursor pr
otein (APP). APLP1, APLP2, and APP contain highly homologous amino aci
d sequences, especially in their cytoplasmic domains, although APLPs l
ack the beta-amyloid domain derived by proteolytic processing from APP
. APP is phosphorylated at three sites in the cytoplasmic domain in cu
ltured cells and adult rat brain [Suzuki et al. (1994) EMBO J. 13, 111
4-1122; Oishi, et al. (1997) Mel. Med. 3, 109-121] and at sites in the
extracellular domain in cultured cells [Knops et al. (1993) Biochem.
Biophys. Res. Commun. 197, 380-385; Hung & Selkoe (1994) EMBO J. 13, 5
34-542; Waiter et al. (1997) J. Biol. Chem. 272, 1896-1903]. We report
here that a cytoplasmic domain peptide from APLP1 is phosphorylated i
n vitro by protein kinase C and that a cytoplasmic domain peptide from
APLP2 is phosphorylated in vitro by protein kinase C and cdc2 kinase.
APLP2 is phosphorylated by cdc2 kinase at a site homologous to the cd
c2 kinase site phosphorylated in APP. Furthermore, phosphorylation of
this site occurs in a cell cycle-dependent manner in cultured cells. T
hese findings indicate that in intact cells the phosphorylation of APL
P2 appears to be regulated in a similar fashion to that of APP.